Consortia
Memberships
Plan S
ASAP is a proud member of Plan S, an initiative for Open Access publishing. The plan is supported by cOAlition S, an international consortium of research funding and performing organizations. Plan S requires that, from 2021, scientific publications that result from research funded by public grants must be published in compliant Open Access journals or platforms.
Open Research Funders Group
ASAP is proud to join alongside philanthropic organizations as a member of The Open Research Funders Group (ORFG). ORFG is a partnership of funding organizations committed to the open sharing of research outputs and other forms of scholarship. The ORFG has two primary programmatic pillars: (1) engaging philanthropies in a community of practice to develop, implement, oversee, and advance strategies that accelerate access to funded research, including papers and data; and (2) serving as the funders’ voice in cross-sector discussions about open research policies, incentives, infrastructure, and good practices.
AMP® PDRD
The Accelerating Medicine Partnership in Parkinson’s Disease and Related Disorders (AMP® PDRD) is a public-private partnership between the National Institutes of Health (NIH), multiple biopharmaceutical and life science companies, and nonprofit organizations. Managed through the Foundation for the NIH (FNIH), AMP® PDRD aims to harmonize Parkinson’s and related disease datasets across the community with the goal of identifying and validating diagnostic, prognostic, and/or progression biomarkers for Parkinson’s disease, with an emphasis on broadening data sharing in the biomedical community to advance Parkinson’s research. ASAP is proud to be a partner in the AMP® PDRD effort to broaden data sharing in the biomedical community to advance Parkinson’s research. Both GP2 and PPMI cohorts share their data on this platform.
News & Updates
Our initiative is accelerating the pace of discovery for Parkinson’s disease through collaboration, research-enabling resources, and data sharing.
The End of the ‘One-Size-Fits-All’ Parkinson’s Diagnosis: Why 2026 Is the Year Neurology Goes High-Resolution
August 14, 2026
In a commentary published in Bio-IT World, ASAP Managing Director Sonya Dumanis shares how Parkinson's disease diagnosis and treatment is shifting away from broad symptom management towards a precision medicine approach grounded in molecular profiling, novel biomarkers, and global data-sharing.
Learn More
ASAP Research Round-Up | Q2 2026
July 27, 2026
In this Q2 2026 edition of the ASAP Research Round-Up, we highlight how our programs produced resources for the scientific community, supported venues that facilitate collaboration, and provided new opportunities for researchers to accelerate discoveries in Parkinson’s research.
Learn More
ASAP Collaborative Research Network (CRN) Impact Report 2025-2026
July 16, 2026
As an extension of the ASAP CRN Impact Report 2020–2024, this report highlights the cross-cutting scientific themes, field-enabling resources, infrastructure efforts, and key discoveries accelerating breakthroughs in PD research across our Collaborative Research Network (CRN).
Learn More